Science_NN1 :_PUN When_CJS suicide_NN1 can_VM0 be_VBI good_AJ0 for_PRP your_DPS long-term_AJ0 healthRoger_NN1 Highfield_NP0 discusses_VVZ new_AJ0 insights_NN2 into_PRP the_AT0 body_NN1 's_POS ways_NN2 of_PRF controlling_VVG its_DPS own_DT0 development_NN1
By_PRP ROGER_NP0 HIGHFIELD_NP0
THEY_PNP died_VVD for_PRP the_AT0 greater_AJC good_NN1 ._PUN
During_PRP your_DPS lifetime_NN1 and_CJC throughout_PRP your_DPS body_NN1 ,_PUN cells_NN2 are_VBB perishing_VVG on_PRP-AVP your_DPS behalf_NN1 ._PUN
In_PRP a_AT0 flourish_NN1 of_PRF biochemical_AJ0 altruism_NN1 ,_PUN they_PNP manufacture_VVB deadly_AJ0 molecules_NN2 and_CJC then_AV0 turn_VVB this_DT0 lethal_AJ0 cocktail_NN1 upon_PRP themselves_PNX ._PUN
In_PRP effect_NN1 ,_PUN they_PNP commit_VVB suicide_NN1 ._PUN
This_DT0 extraordinary_AJ0 process_NN1 of_PRF programmed_AJ0 cell_NN1 death_NN1 has_VHZ long_AV0 been_VBN regarded_VVN as_CJS essential_AJ0 to_PRP development_NN1 ,_PUN the_AT0 process_NN1 of_PRF growth_NN1 from_PRP spherical_AJ0 egg_NN1 to_PRP an_AT0 entire_AJ0 human_AJ0 being_NN1 ._PUN
In_PRP one_CRD example_NN1 of_PRF biological_AJ0 origami_NN2 ,_PUN two_CRD flaps_NN2 of_PRF tissue_NN1 fuse_NN1-VVB to_TO0 form_VVI the_AT0 palate_NN1 in_PRP the_AT0 mouth_NN1 ;_PUN mass_AJ0 suicide_NN1 of_PRF cells_NN2 takes_VVZ place_NN1 at_PRP the_AT0 join_NN1-VVB ._PUN
In_PRP the_AT0 current_AJ0 issue_NN1 of_PRF Nature_NN1 ,_PUN a_AT0 bold_AJ0 suggestion_NN1 is_VBZ now_AV0 made_VVN by_PRP Prof_NP0 Martin_NP0 Raff_NN1-NP0 of_PRF University_NN1 College_NN1 London_NP0 that_DT0-CJT cell_NN1 suicide_NN1 is_VBZ more_AV0 fundamental_AJ0 than_CJS previously_AV0 thought_VVN ._PUN
‘_PUQ Cell_NN1 death_NN1 occurs_VVZ in_PRP-AVP all_DT0 animals_NN2 and_CJC all_DT0 tissues_NN2 ,_PUN at_PRP least_AV0 at_PRP some_DT0 stage_NN1 of_PRF development_NN1 ._PUN
It_PNP occurs_VVZ on_PRP-AVP a_AT0 much_AV0 larger_AJC scale_NN1 than_CJS generally_AV0 realised_VVN and_CJC in_PRP most_DT0 cases_NN2 the_AT0 function_NN1 is_VBZ unclear_AJ0 ._PUN ’_PUQ
Cellular_AJ0 hara-kiri_NN1 was_VBD first_ORD dubbed_VVN ‘_PUQ apoptosis_NN1 ’_PUQ (_PUL the_AT0 second_ORD ‘_PUQ p_ZZ0 ’_PUQ is_VBZ silent_AJ0 )_PUR by_PRP Alastair_NP0 Currie_NP0 ,_PUN John_NP0 Kerr_NP0 and_CJC Andrew_NP0 Wyllie_NP0 at_PRP the_AT0 University_NN1 of_PRF Edinburgh_NP0 ._PUN
In_PRP just_AV0 a_AT0 few_DT0 hours_NN2 ,_PUN a_AT0 doomed_AJ0 cell_NN1 separates_VVZ from_PRP its_DPS neighbours_NN2 and_CJC shrinks_NN2-VVZ ,_PUN while_CJS its_DPS nucleus_NN1 changes_NN2-VVZ shape_NN1-VVB and_CJC fragments_NN2 ._PUN
The_AT0 conventional_AJ0 view_NN1 is_VBZ that_CJT the_AT0 body_NN1 —_PUN somehow_AV0 —_PUN tells_VVZ these_DT0 altruistic_AJ0 cells_NN2 to_TO0 do_VDI the_AT0 honourable_AJ0 thing_NN1 by_PRP activating_VVG a_AT0 suicide_NN1 programme_NN1 ._PUN
But_CJC Raff_NP0-NN1 speculates_VVZ that_CJT it_PNP makes_VVZ more_DT0 sense_NN1 that_CJT all_DT0 cells_NN2 are_VBB suicidal_AJ0 :_PUN to_TO0 survive_VVI they_PNP have_VHB to_TO0 be_VBI constantly_AV0 reminded_VVN by_PRP signals_NN2 from_PRP the_AT0 body_NN1 that_CJT they_PNP are_VBB loved_VVN and_CJC cherished_VVD-AJ0 ._PUN
He_PNP cites_VVZ evidence_NN1 from_PRP the_AT0 developing_AJ0 nervous_AJ0 system_NN1 ._PUN
Most_DT0 nerve_NN1-VVB cells_NN2 are_VBB overproduced_VVN in_PRP the_AT0 embryo_NN1 ._PUN
The_AT0 cells_NN2 seem_VVB to_TO0 compete_VVI for_PRP survival_NN1 factors_NN2 released_VVN by_PRP target_NN1 cells_NN2 that_CJT the_AT0 nerve_NN1 cells_NN2 contact_VVB-NN1 ;_PUN about_AV0 half_DT0 get_VVB enough_DT0 to_TO0 survive_VVI ,_PUN the_AT0 rest_NN1 kill_VVB themselves_PNX ._PUN
The_AT0 adult_NN1-AJ0 rat_NN1 provides_VVZ another_DT0 example_NN1 :_PUN it_PNP has_VHZ been_VBN found_VVN that_CJT cells_NN2 in_PRP its_DPS prostate_NN1 gland_NN1 need_VVB-NN1 the_AT0 hormone_NN1 testosterone_NN1 ._PUN
Without_PRP it_PNP ,_PUN they_PNP commit_VVB suicide_NN1 ._PUN
‘_PUQ It_PNP seems_VVZ an_AT0 attractive_AJ0 idea_NN1 that_CJT this_DT0 might_VM0 be_VBI a_AT0 general_AJ0 scheme_NN1 for_PRP all_DT0 cells_NN2 ,_PUN ’_PUQ he_PNP said_VVD ._PUN
It_PNP would_VM0 act_VVI ,_PUN for_PRP example_NN1 ,_PUN as_CJS-PRP a_AT0 general_AJ0 mechanism_NN1 to_TO0 wipe_VVI out_AVP those_DT0 that_CJT end_VVB up_AVP in_PRP the_AT0 wrong_AJ0 place_NN1 ,_PUN say_VVB after_CJS a_AT0 cut_NN1-AJ0 mixes_VVZ-NN2 cells_NN2 between_PRP different_AJ0 layers_NN2 of_PRF skin_NN1 ._PUN
The_AT0 traditional_AJ0 view_NN1 of_PRF cell_NN1 suicide_NN1 focuses_VVZ on_PRP development_NN1 :_PUN it_PNP helps_VVZ the_AT0 tadpole_NN1 to_TO0 lose_VVI its_DPS tail_NN1 ;_PUN it_PNP dissolves_VVZ the_AT0 tissues_NN2 of_PRF the_AT0 caterpillar_NN1 when_CJS-AVQ the_AT0 time_NN1 comes_VVZ for_PRP change_NN1 into_PRP a_AT0 moth_NN1 ;_PUN in_PRP a_AT0 mother_NN1 's_POS womb_NN1 ,_PUN it_PNP severs_VVZ the_AT0 webs_NN2 between_PRP the_AT0 digits_NN2 of_PRF a_AT0 child_NN1 's_POS developing_AJ0 hands_NN2 and_CJC feet_NN2 ._PUN
Apoptosis_NN1-NP0 also_AV0 plays_VVZ an_AT0 important_AJ0 role_NN1 in_PRP the_AT0 ever-present_AJ0 battle_NN1 against_PRP infection_NN1 ._PUN
When_CJS-AVQ white_AJ0 blood_NN1 cells_NN2 attack_VVB-NN1 cells_NN2 infected_VVN with_PRP an_AT0 invader_NN1 ,_PUN this_DT0 is_VBZ murder_NN1 ,_PUN not_XX0 suicide_NN1 ._PUN
But_CJC suicide_NN1 has_VHZ been_VBN shown_VVN to_TO0 have_VHI important_AJ0 roles_NN2 in_PRP our_DPS immune_AJ0 system_NN1 ._PUN
It_PNP eliminates_VVZ white_AJ0 blood_NN1 cells_NN2 that_CJT could_VM0 react_VVI against_PRP the_AT0 body_NN1 's_POS own_DT0 normal_AJ0 cells_NN2 ._PUN
If_CJS these_DT0 ‘_PUQ self-reacting_AJ0 ’_PUQ cells_NN2 were_VBD not_XX0 eliminated_VVN ,_PUN they_PNP could_VM0 cause_VVI auto-immune_AJ0 diseases_NN2 such_DT0 as_PRP arthritis_NN1 and_CJC multiple_AJ0 sclerosis_NN1 ._PUN
In_PRP a_AT0 paper_NN1 published_VVD this_DT0 month_NN1 in_PRP Nature_NN1 by_PRP Dr_NP0 Shigekazu_NP0 Nagata_NP0 from_PRP the_AT0 Osaka_NP0 Bioscience_NP0 Institute_NN1 in_PRP Japan_NP0 ,_PUN it_PNP was_VBD found_VVN that_CJT a_AT0 strain_NN1 of_PRF mice_NN2 long_AV0 known_VVN to_TO0 suffer_VVI from_PRP auto-immune_AJ0 disease_NN1 lacks_VVZ a_AT0 working_AJ0 version_NN1 of_PRF a_AT0 gene_NN1 called_VVD Fas_NP0 ._PUN
This_DT0 finding_NN1 suggests_VVZ that_CJT the_AT0 Fas_NP0 gene_NN1 is_VBZ involved_AJ0 in_PRP the_AT0 signalling_NN1 mechanism_NN1 that_CJT normally_AV0 causes_VVZ the_AT0 self-reactive_AJ0 white_AJ0 blood_NN1 cells_NN2 to_TO0 die_VVI ._PUN
In_PRP this_DT0 way_NN1 ,_PUN Nagata_NP0 found_VVD an_AT0 intriguing_AJ0 connection_NN1 between_PRP programmed_AJ0 cell_NN1 death_NN1 ,_PUN auto-immune_AJ0 and_CJC hereditary_AJ0 disease_NN1 that_CJT may_VM0 lead_VVI to_PRP a_AT0 deeper_AJC understanding_NN1 of_PRF these_DT0 diseases_NN2 in_PRP humans_NN2 ._PUN
Cancer_NN1 researchers_NN2 are_VBB also_AV0 interested_AJ0 in_PRP apoptosis_NN1 ._PUN
The_AT0 growth_NN1 of_PRF a_AT0 tumour_NN1 is_VBZ regulated_VVN both_AV0 by_PRP the_AT0 rate_NN1 at_PRP which_DTQ its_DPS cells_NN2 divide_VVB-NN1 and_CJC the_AT0 rate_NN1 of_PRF apoptosis_NN1 ._PUN
Aids_NN2 researchers_NN2 are_VBB now_AV0 investigating_VVG if_CJS HIV_NP0 is_VBZ somehow_AV0 triggering_VVG the_AT0 suicide_NN1 response_NN1 of_PRF protective_AJ0 white_AJ0 blood_NN1 cells_NN2 ,_PUN stripping_VVG the_AT0 body_NN1 of_PRF immunity_NN1 ._PUN
To_PRP date_NN1 ,_PUN research_NN1 has_VHZ focused_VVN on_PRP the_AT0 most_AV0 obvious_AJ0 feature_NN1 of_PRF living_AJ0-VVG things_NN2 :_PUN cell_NN1 multiplication_NN1 ._PUN
‘_PUQ This_DT0 is_VBZ taking_VVG the_AT0 idea_NN1 one_CRD step_NN1-VVB further_AV0 ,_PUN ’_PUQ Raff_NP0 said_VVD ._PUN
‘_PUQ Cells_NN2 need_VVB signals_NN2 not_XX0 only_AV0 to_TO0 proliferate_VVI but_CJC also_AV0 to_TO0 survive_VVI ._PUN ’_PUQ
Science_NN1 :_PUN Shape_NN1 of_PRF sounds_NN2 to_TO0 come_VVI
By_PRP ROGER_NP0 HIGHFIELD_NP0
ACENTURY-old_AJ0 mathematical_AJ0 problem_NN1 that_CJT borders_NN2 on_PRP the_AT0 psychedelic_NN1-AJ0 has_VHZ been_VBN solved_VVN :_PUN can_VM0 you_PNP hear_VVI shapes_NN2 ?_PUN
The_AT0 latest_AJS Bulletin_NN1 of_PRF the_AT0 American_AJ0 Mathematical_AJ0 Society_NN1 resolves_VVZ a_AT0 question_NN1 that_CJT came_VVD to_PRP light_NN1 in_PRP the_AT0 days_NN2 of_PRF Lord_NP0 Rayleigh_NP0 ,_PUN who_PNQ showed_VVD how_AVQ an_AT0 idealised_AJ0 object_NN1 called_VVN a_AT0 black_AJ0 body_NN1 radiates_VVZ heat_NN1 and_CJC light_AJ0 energy_NN1 ._PUN
Whether_CJS two_CRD different_AJ0 surfaces_NN2 of_PRF the_AT0 same_DT0 area_NN1 have_VHB the_AT0 same_DT0 radiation_NN1 signature_NN1 was_VBD generalised_VVN-AJ0 to_PRP the_AT0 point_NN1 where_AVQ mathematicians_NN2 asked_VVD if_CJS drums_NN2 of_PRF the_AT0 same_DT0 perimeter_NN1 and_CJC area_NN1 ,_PUN but_CJC different_AJ0 shape_NN1 ,_PUN had_VHD different_AJ0 sounds_NN2 :_PUN could_VM0 one_PNI hear_VVI the_AT0 shape_NN1 of_PRF a_AT0 drum_NN1 ?_PUN
The_AT0 answer_NN1 is_VBZ no_ITJ ,_PUN say_VVB Prof_NP0 Carolyn_NP0 Gordon_NP0 and_CJC Dr_NP0 David_NP0 Webb_NP0 of_PRF Washington_NP0 University_NN1 in_PRP St_NP0 Louis_NP0 ,_PUN with_PRP Dr_NP0 Scott_NP0 Wolpert_NN1-NP0 of_PRF the_AT0 University_NN1 of_PRF Maryland_NP0 ._PUN
This_DT0 could_VM0 have_VHI implications_NN2 for_PRP engineers_NN2 using_VVG changes_NN2 in_PRP the_AT0 sound_NN1 of_PRF vibrating_VVG-AJ0 components_NN2 to_TO0 check_VVI for_PRP cracks_NN2 and_CJC fractures_NN2 ._PUN
With_PRP a_AT0 geometrical_AJ0 approach_NN1 using_VVG generalised_AJ0 surfaces_NN2 called_VVN orbifolds_NN2 and_CJC a_AT0 recent_AJ0 theorem_NN1 of_PRF French_AJ0 mathematician_NN1 Pierre_NP0 Berard_NP0 ,_PUN they_PNP showed_VVD that_CJT two_CRD differently_AV0 shaped_AJ0-VVN drum_NN1 skins_NN2 could_VM0 produce_VVI the_AT0 same_DT0 sound_NN1 ._PUN
Even_AV0 with_PRP a_AT0 perfect_AJ0 ear_NN1 ,_PUN you_PNP could_VM0 not_XX0 determine_VVI which_DTQ shapes_VVZ you_PNP were_VBD listening_VVG to_PRP ,_PUN they_PNP say_VVB ._PUN
But_CJC Gordon_NP0 concedes_VVZ they_PNP ‘_PUQ are_VBB unusual_AJ0 shapes_NN2 ’_PUQ ._PUN
Business_NN1 Technology_NN1 :_PUN Treating_VVG Aids_NN2 with_PRP a_AT0 trick_NN1 gene_NN1 Christine_NP0 McGourty_NP0 looks_VVZ at_PRP long-term_AJ0 therapy_NN1 that_CJT could_VM0 prevent_VVI the_AT0 HIV_NP0 virus_NN1 reproducing_VVG
By_PRP CHRISTINE_NP0 MCGOURTY_NP0-NN1
A_AT0 LABORATORY_NN1 will_VM0 be_VBI built_VVN at_PRP Oxford_NP0 University_NN1 this_DT0 summer_NN1 to_TO0 house_VVI a_AT0 new_AJ0 research_NN1 team_NN1 studying_VVG gene_NN1 therapy_NN1 for_PRP the_AT0 treatment_NN1 of_PRF Aids_NN2 ._PUN
It_PNP is_VBZ being_VBG set_VVN up_AVP with_PRP more_AV0 than_CJS £1_NN0 million_CRD over_AV0 five_CRD years_NN2 from_PRP British_AJ0 Biotechnology_NN1 Ltd_AJ0 ,_PUN one_CRD of_PRF a_AT0 rare_AJ0 breed_NN1 in_PRP Britain_NP0 :_PUN a_AT0 world-class_AJ0 biotechnology_NN1 company_NN1 successfully_AV0 transferring_VVG technology_NN1 from_PRP academia_NN1 into_PRP the_AT0 marketplace_NN1 ._PUN
The_AT0 new_AJ0 laboratory_NN1 will_VM0 employ_VVI six_CRD to_PRP 10_CRD people_NN0 in_PRP an_AT0 area_NN1 of_PRF science_NN1 that_CJT-DT0 is_VBZ not_XX0 expected_VVN-AJ0 to_TO0 produce_VVI marketable_AJ0 results_NN2 for_PRP five_CRD to_PRP 10_CRD years_NN2 ._PUN
The_AT0 aim_NN1 of_PRF the_AT0 fundamentally_AV0 new_AJ0 and_CJC untested_AJ0 approach_NN1 to_PRP the_AT0 treatment_NN1 of_PRF Aids_NN2 is_VBZ to_TO0 inject_VVI patients_NN2 with_PRP ‘_PUQ fake_AJ0 ’_PUQ copies_NN2 of_PRF the_AT0 Aids_NN1 virus_NN1 ,_PUN carrying_VVG an_AT0 anti-Aids_AJ0 gene_NN1 ,_PUN to_TO0 prevent_VVI reproduction_NN1 of_PRF the_AT0 real_AJ0 virus_NN1 ._PUN
Using_VVG new_AJ0 ‘_PUQ viral_AJ0 engineering_NN1 ’_PUQ techniques_NN2 ,_PUN researchers_NN2 would_VM0 use_VVI the_AT0 protein_NN1 ‘_PUQ coat_NN1 ’_PUQ of_PRF the_AT0 Aids_NN1 virus_NN1 but_CJC remove_VVB harmful_AJ0 genes_NN2 wrapped_VVN-VVD inside_PRP it_PNP ._PUN
In_PRP their_DPS place_NN1 ,_PUN they_PNP would_VM0 insert_VVI a_AT0 gene_NN1 that_CJT prevents_VVZ reproduction_NN1 of_PRF the_AT0 real_AJ0 virus_NN1 ._PUN
‘_PUQ The_AT0 modified_AJ0 virus_NN1 would_VM0 go_VVI off_AVP and_CJC bind_VVI to_PRP the_AT0 cells_NN2 in_PRP the_AT0 body_NN1 that_CJT HIV_NP0 normally_AV0 binds_VVZ to_TO0 ._PUN
But_CJC instead_AV0 of_PRF putting_VVG an_AT0 HIV_NP0 gene_NN1 into_PRP the_AT0 cell_NN1 ,_PUN it_PNP would_VM0 put_VVI in_PRP-AVP a_AT0 gene_NN1 for_PRP an_AT0 inhibitor_NN1 ,_PUN ’_PUQ said_VVD Dr_NP0 Alan_NP0 Kingsman_NP0 ,_PUN who_PNQ will_VM0 head_VVI the_AT0 new_AJ0 laboratory_NN1 ._PUN
In_PRP HIV-infected_AJ0 patients_NN2 the_AT0 treatment_NN1 could_VM0 shut_VVI down_AVP production_NN1 of_PRF the_AT0 virus_NN1 and_CJC prevent_VVB the_AT0 onset_NN1 of_PRF Aids_NN2 and_CJC it_PNP could_VM0 prevent_VVI infection_NN1 in_PRP healthy_AJ0 patients_NN2 ._PUN
‘_PUQ We_PNP know_VVB broadly_AV0 how_AVQ to_TO0 do_VDI it_PNP ,_PUN ’_PUQ Kingsman_NP0 said_VVD ._PUN
‘_PUQ We_PNP have_VHB already_AV0 taken_VVN the_AT0 first_ORD steps_NN2 towards_PRP that_DT0 goal_NN1 ._PUN
We_PNP can_VM0 make_VVI a_AT0 safe_AJ0 virus_NN1 that_CJT-DT0 is_VBZ a_AT0 derivative_NN1 of_PRF HIV_NP0 and_CJC will_VM0 still_AV0 infect_VVI the_AT0 cells_NN2 susceptible_AJ0 to_PRP the_AT0 Aids_NN1 virus_NN1 ._PUN ’_PUQ
At_PRP a_AT0 meeting_NN1 last_ORD week_NN1 of_PRF Isis_NP0 Innovation_NN1 ,_PUN Oxford_NP0 University_NN1 's_POS technology_NN1 transfer_NN1-VVB company_NN1 ,_PUN Kingsman_NP0 said_VVD the_AT0 technique_NN1 was_VBD ‘_PUQ exciting_AJ0 and_CJC new_AJ0 ’_PUQ ._PUN
‘_PUQ It_PNP goes_VVZ beyond_PRP conventional_AJ0 drug_NN1 design_NN1 ._PUN
We_PNP might_VM0 be_VBI able_AJ0 to_TO0 design_VVI other_AJ0 viruses_NN2 that_CJT deliver_VVB tumour_NN1 suppressor_NN1 genes_NN2 to_TO0 prevent_VVI cancer_NN1 ._PUN ’_PUQ
The_AT0 main_AJ0 potential_AJ0-NN1 problem_NN1 was_VBD the_AT0 efficiency_NN1 of_PRF the_AT0 replacement_NN1 genes_NN2 designed_VVN to_TO0 prevent_VVI the_AT0 Aids_NN1 virus_NN1 reproducing_VVG itself_PNX ._PUN
‘_PUQ We_PNP know_VVB we_PNP can_VM0 get_VVI the_AT0 inhibitor_NN1 genes_NN2 into_PRP a_AT0 cell_NN1 but_CJC we_PNP ca_VM0 n't_XX0 tell_VVI whether_CJS we_PNP 'll_VM0 be_VBI able_AJ0 to_TO0 produce_VVI this_DT0 inhibitor_NN1 efficiently_AV0 enough_AV0 until_CJS we_PNP test_VVB it_PNP ._PUN
There_EX0 are_VBB indications_NN2 that_CJT it_PNP will_VM0 be_VBI possible_AJ0 ._PUN ’_PUQ
He_PNP also_AV0 said_VVD there_EX0 were_VBD significant_AJ0 regulatory_AJ0 hurdles_NN2 to_TO0 be_VBI overcome_VVN before_PRP the_AT0 new_AJ0 ‘_PUQ gene_NN1 therapy_NN1 ’_PUQ technique_NN1 was_VBD accepted_VVN ._PUN
‘_PUQ There_EX0 are_VBB many_DT0 reservations_NN2 about_PRP whether_CJS it_PNP would_VM0 be_VBI approved_VVN ethically_AV0 ._PUN ’_PUQ
BBL_NP0 has_VHZ just_AV0 opened_VVN a_AT0 facility_NN1 to_TO0 make_VVI an_AT0 Aids_NN1 vaccine_NN1 ,_PUN a_AT0 different_AJ0 product_NN1 also_AV0 based_VVN on_PRP technology_NN1 developed_VVN by_PRP Kingsman_NP0-NN1 ._PUN
The_AT0 first_ORD trials_NN2 on_PRP HIV-infected_AJ0 individuals_NN2 are_VBB planned_VVN for_PRP later_AV0 this_DT0 year_NN1 ._PUN
It_PNP will_VM0 be_VBI the_AT0 first_ORD Aids_NN1 vaccine_NN1 trial_NN1 in_PRP Britain_NP0 ._PUN
With_PRP Celltech_NP0-NN1 and_CJC a_AT0 handful_NN1 of_PRF smaller_AJC companies_NN2 ,_PUN BBL_NP0 represents_VVZ the_AT0 best_AJS of_PRF British_AJ0 biotechnology_NN1 ._PUN
Though_CJS in_PRP America_NP0 there_EX0 are_VBB about_AV0 1,000_CRD biotechnology_NN1 companies_NN2 ,_PUN 100_CRD of_PRF which_DTQ are_VBB successful_AJ0 ,_PUN in_PRP Britain_NP0 they_PNP are_VBB rare_AJ0 ._PUN
Stephen_NP0 Burrill_NP0 ,_PUN an_AT0 analyst_NN1 with_PRP Ernst_NP0 and_CJC Young_NP0 in_PRP San_NP0 Francisco_NP0 ,_PUN and_CJC author_NN1 of_PRF a_AT0 new_AJ0 report_NN1 on_PRP the_AT0 industry_NN1 ,_PUN said_VVD promises_NN2 had_VHD finally_AV0 become_VVB reality_NN1 in_PRP America_NP0 ._PUN
‘_PUQ Until_PRP now_AV0 there_EX0 's_VHZ been_VBN quite_AV0 an_AT0 expectation_NN1 gap_NN1 ._PUN
People_NN0 got_VVD-VVN carried_VVN away_AV0 about_PRP how_AVQ quickly_AV0 the_AT0 research_NN1 would_VM0 be_VBI commercialised_VVN ._PUN
Now_AV0 it_PNP 's_VBZ being_VBG commercialised_VVN in_PRP earnest_NN1 ._PUN ’_PUQ
In_PRP an_AT0 astonishing_AJ0 burst_NN1 of_PRF enthusiasm_NN1 for_PRP biotech_NN1 last_ORD year_NN1 ,_PUN 60_CRD such_DT0 companies_NN2 raised_VVD-VVN a_AT0 total_NN1 of_PRF $3.7_NN0 billion_CRD in_PRP the_AT0 public_AJ0-NN1 equity_NN1 market_NN1 ._PUN
California_NP0 's_POS Amgen_NN1-NP0 ,_PUN the_AT0 jewel_NN1 in_PRP the_AT0 crown_NN1 of_PRF American_AJ0 biotechnology_NN1 ,_PUN is_VBZ set_VVN to_TO0 become_VVI the_AT0 industry_NN1 's_POS first_ORD to_TO0 enter_VVI the_AT0 Fortune_NN1 500_CRD list_NN1 of_PRF America_NP0 's_POS top_AJ0-NN1 companies_NN2 ,_PUN with_PRP revenue_NN1 of_PRF $1_NN0 billion_CRD expected_VVD this_DT0 year_NN1 ._PUN
But_CJC the_AT0 British_AJ0 industry_NN1 is_VBZ ‘_PUQ way_NN1 behind_AV0 ’_PUQ ,_PUN Burrill_NP0 said_VVD ._PUN
‘_PUQ It_PNP 's_VHZ been_VBN slow_AJ0 to_TO0 develop_VVI ,_PUN despite_PRP the_AT0 fact_NN1 that_CJT the_AT0 science_NN1 and_CJC technology_NN1 is_VBZ world_NN1 class_NN1 ._PUN
The_AT0 UK_NP0 is_VBZ not_XX0 very_AV0 entrepreneurial_AJ0 ._PUN
Most_DT0 of_PRF the_AT0 entrepreneurs_NN2 have_VHB come_VVN to_PRP the_AT0 US_NP0 because_CJS of_PRF the_AT0 access_NN1 to_PRP capital_NN1 and_CJC the_AT0 willingness_NN1 to_TO0 accept_VVI risk_NN1 ._PUN
‘_PUQ There_EX0 's_VHZ been_VBN a_AT0 bit_NN1 of_PRF a_AT0 brain_NN1 drain_NN1 from_PRP Britain_NP0 and_CJC relatively_AV0 little_AV0-AJ0 real_AJ0 commercial_AJ0 activity_NN1 there_AV0 ._PUN
Things_NN2 are_VBB changing_VVG-AJ0 but_CJC not_XX0 with_PRP the_AT0 speed_NN1 you_PNP 'd_VM0 like_VVI ._PUN ’_PUQ
It_PNP could_VM0 take_VVI as_AV0 much_DT0 as_CJS 10_CRD years_NN2 for_PRP the_AT0 industry_NN1 to_TO0 mature_VVI to_PRP the_AT0 stage_NN1 that_CJT America_NP0 's_POS is_VBZ at_PRP now_AV0 ._PUN
Though_CJS its_DPS industry_NN1 is_VBZ behind_AV0 ,_PUN Britain_NP0 's_POS researchers_NN2 still_AV0-AJ0 rank_VVB-NN1 among_PRP the_AT0 world_NN1 's_VBZ best_AJS in_PRP the_AT0 science_NN1 that_CJT underpins_VVZ biotechnology_NN1 ._PUN
A_AT0 vote_NN1 of_PRF confidence_NN1 comes_VVZ this_DT0 week_NN1 from_PRP Genzyme_NP0-NN1 ,_PUN one_CRD of_PRF America_NP0 's_POS top_AJ0 10_CRD biotechnology_NN1 companies_NN2 ._PUN
On_PRP Wednesday_NP0 ,_PUN the_AT0 Duke_NN1 of_PRF Kent_NP0 will_VM0 open_VVI a_AT0 major_AJ0 new_AJ0 research_NN1 and_CJC development_NN1 centre_NN1 at_PRP West_NN1 Malling_VVG in_PRP Kent_NP0 ,_PUN which_DTQ will_VM0 host_VVI research_NN1 into_PRP biotherapeutics_NN2 ,_PUN diagnostics_NN1 and_CJC fine_AJ0 chemicals_NN2 ._PUN
